Introduction. p53: The first twenty years

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 9-11

  Oren, M ^a   Rotter, V ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Cancer; Cell cycle; Differentiation; DNA repair; p53; Phosphorylation; Tumour suppressors

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ANIMAL MODEL; APOPTOSIS; BIOCHEMISTRY; CARCINOGENESIS; CELL CYCLE; DEVELOPMENTAL GENETICS; DNA REPAIR; DNA TUMOR VIRUS; HUMAN; MOUSE; NONHUMAN; SHORT SURVEY; SIMIAN VIRUS 40; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL CYCLE; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032988122     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050265     Document Type: Short Survey

References (19)

1. 1 Kress M., May E., Cassingena R. and May P. (1979) Simian virus-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J. Virol. 31: 472-483
2. 2 Lane D. P. and Crawford L. V. (1979) T-antigen is bound to host protein in SV40-transformed cells. Nature 278: 261-263
3. 3 Linzer D. I. H. and Levine A. J. (1979) Characterization of a 54K dalton cellular SV40 tumour antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52
4. 4 Ko L. J. and Prives C. (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
5. 5 Hansen R. and Oren M. (1997) p53: from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7: 46-51
6. 6 Levine A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
7. 7 Morgan S. E. and Kastan M. B. (1997) p53 and ATM: cell cycle, cell death and cancer. Adv. Cancer Res. 71: 1-25
8. 8 Agarwal M. L., Taylor W. R., Chernov M. V., Chernova O. B. and Stark G. R. (1998) The p53 network. J. Biol. Chem. 273: 1-4
9. 9 El-Deiry W. S. (1998) p21/p53, cellular growth control and genomic integrity. Curr. Top. Microbiol. Immunol. 227: 121-37
10. 10 Mowat M. R. (1998) p53 in tumour progression: life, death and everything. Adv. Cancer Res. 74: 25-48
11. 11 Almog N. and Rotter V. (1998) An insight into the life of p53: a protein coping with many functions exclaim. Biochim. Biophys. Acta Rev. Cancer 1378: R43-R54
12. 12 Lane D. P. (1992) p53, guardian of the genome. Nature 358: 15-16
13. 13 El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M. et al. (1993) WAF1, a potential mediator of p53 tumour suppression. Cell 75: 817-825
14. 14 Harper J. W., Adami G. R., Wei N., Keyomarsi K. and Elledge S. J. (1993) The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75: 805-816
15. 15 Deng C. X., Zhang P. M., Harper J. W., Elledge S. J. and Leder P. (1995) Mice lacking p21(CIP1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell. 82: 675-684
16. 16 Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T. and Hannon G. J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557
17. 17 Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A. Jr., Butel J. S. et al. (1992) Mice deficient for p53 are developmentally normal bul susceptible to spontaneous tumours. Nature 356: 215-221
18. 18 Montes de Oca Luna R., Wagner D. S. and Lozano G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206
19. 19 Jones S. N., Roe A. E., Donehower L. A. and Bradley A. (1995) Rescue of embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378: 206-208